Management of hepatitis B virus reactivation in patients with hematological malignancies treated with chemotherapy

Infection

Volumn 38, Issue 1, 2010, Pages 58-61

  Francisci, D ^a   Falcinelli, F ^a   Schiaroli, E ^a   Capponi, M ^a   Belfiori, B ^a   Flenghi, L ^a   Baldelli, F ^a  

^a UNIVERSITY OF PERUGIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ADEFOVIR; AMINOTRANSFERASE; ANTINEOPLASTIC AGENT; HEPATITIS B CORE ANTIGEN; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B VACCINE; LAMIVUDINE; RITUXIMAB; VIRUS DNA;

ACUTE LEUKEMIA; ADOLESCENT; ADULT; AGED; ARTICLE; CANCER PATIENT; CHRONIC LEUKEMIA; COHORT ANALYSIS; DISEASE COURSE; FEMALE; HEMATOLOGIC MALIGNANCY; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS C VIRUS; HUMAN; INCIDENCE; INFECTION PREVENTION; LIVER FUNCTION; MAJOR CLINICAL STUDY; MALE; MULTIPLE MYELOMA; MYELODYSPLASTIC SYNDROME; NONHODGKIN LYMPHOMA; NONHUMAN; OBSERVATIONAL STUDY; PREVALENCE; PROSPECTIVE STUDY; SEROCONVERSION; VIRUS REACTIVATION;

ADOLESCENT; ADULT; AGED; ANTINEOPLASTIC AGENTS; ANTIVIRAL AGENTS; DRUG THERAPY; FEMALE; HEMATOLOGIC NEOPLASMS; HEPACIVIRUS; HEPATITIS B; HEPATITIS B VIRUS; HUMANS; IMMUNOCOMPROMISED HOST; ITALY; LIVER FUNCTION TESTS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; VIRUS ACTIVATION; YOUNG ADULT;

EID: 77549084321     PISSN: 03008126     EISSN: None     Source Type: Journal    
DOI: 10.1007/s15010-009-9019-1     Document Type: Article

References (29)

1. R. Liang G.K. Lau Y.L. Kwong 1999 Chemotherapy and bone marrow transplantation for cancer patients who are also chronic hepatitis B carriers: a review of the problem J Clin Oncol 17 394 398 1:STN:280:DyaK1MzosFCnsg%3D%3D 10458258
2. L. Xunrong A.W. Yan R. Liang G.K. Lau 2001 Hepatitis B virus (HBV) reactivation after cytotoxic or immunosuppressive therapy - pathogenesis and management Rev Med Virol 11 287 299 10.1002/rmv.322 1:STN:280: DC%2BD3MrksVWnsQ%3D%3D 11590667 (Pubitemid 33009970)
3. R.M. Galbraight A.L. Eddleston R. Williams 1975 Fulminating hepatic failure in leukaemia and choriocarcinoma related to withdrawal of cytotoxic drug therapy Lancet 2 528 530
4. S. Takai H. Tsurumi K. Ando 2005 Prevalence of hepatitis B and C virus infections in haematological malignancies and liver injury ollowing chemotherapy European J Haematol 74 156 163
5. J.H. Hoofnagle G. Dusheiko D. R. Schafer M.A. Gerber F. Klian 1982 Reactivation of chronic hepatitis B virus infection by cancer chemotherapy Ann Intern Med 96 446 449
6. L. Xunrong A.W. Yan R. Liang 2001 Hepatitis B virus (HBV) reactivation after cytotoxic or immunosoppressive therapypathogenesis and management Rev Med Virol 11 287 299 10.1002/rmv.322 1:STN:280:DC%2BD3MrksVWnsQ%3D%3D 11590667 (Pubitemid 33009970)
7. R.M. Galbraight A.L. Eddleston R. Williams 1975 Fulminating hepatic failure in leukaemia and choriocarcinoma related to withdrawal of cytotoxic drug therapy Lancet 2 528 530
8. S.N. Thung M.A. Gerber F. Klion 1985 Massive hepatic necrosis after chemotherapy withdrawal in a hepatitis B carrier Arch Intern Med 145 1313 1314 10.1001/archinte.145.7.1313 1:STN:280:DyaL2M3ltVOlsw%3D%3D 4015284 (Pubitemid 15231923)
9. A.S. Lok R.H. Liang E.K. Chiu 1991 Reactivation of hepatitis B virus replication in patients receiving cytotoxic therapy: report of a prospective study Gastroenterology 100 182 188 1:STN:280:DyaK3M%2FmtVSiuw%3D%3D 1983820
10. A. Marzano E. Angelucci P. Andreone 2007 Prophylaxis and treatment of hepatitis B in immunocompromised patients Dig Liv Dis 39 397 408 10.1016/j.dld.2006.12.017 1:CAS:528:DC%2BD2sXmvVehtbk%3D (Pubitemid 46508732)
11. K. Iwai M. Tashima M. Itoh 2000 Fulminant hepatitis B following bone marrow transplantation in an HbsAg-negative, HbsAb positive recipient; reactivation of dormant virus during the immunosuppressive period Bone Marrow transplant 25 105 108 10.1038/sj.bmt.1702093 1:STN:280:DC%2BD3c7itVKqsA%3D%3D 10654023
12. G. Raimondo T. Pollicino I. Cacciolla 2007 Occult hepatitis B infection J Hepatol 46 160 170 10.1016/j.jhep.2006.10.007 17112622 (Pubitemid 44827430)
13. A.L. Cheng C.A. Hsiung L.J. Su 2003 Steroid-free chemotherapy decreases risk of hepatitis B virus (HBV) reactivation in HBV-carriers with lymphoma Hepatology 37 1320 1328 10.1053/jhep.2003.50220 1:CAS:528:DC%2BD3sXkvFWltb4%3D 12774010 (Pubitemid 36667311)
14. Y. Tsutsumi H. Kanamori A. Mori 2005 Reactivationof hepatitis B virus with rituximab Expert Opinion on Drug Safety 4 599 610 10.1517/14740338.4.3.599 1:CAS:528:DC%2BD2MXlsFakt74%3D 15934864 (Pubitemid 40723731)
15. E. Iannitto V. Minardi G. Calvaruso 2005 Hepatitis B virus reactivation and alentuzumab therapy Eur J Haematol 74 254 258 10.1111/j.1600-0609.2004. 00375.x 15693796 (Pubitemid 40278496)
16. C. Sarrecchia A. Cappelli P. Aiello 2005 HBV reactivation with fatal fulminant hepatitis during rituximab treatment in a subject negative for HbsAg and positive for HbsAb and HbcAb J Infect Chemother 11 189 191 10.1007/s10156-005-0385-z 16133710 (Pubitemid 41216450)
17. W.M. Lee 1997 Hepatitis B virus infection New Engl J Med 337 1733 1745 10.1056/NEJM199712113372406 1:STN:280:DyaK1c%2FktFyjtA%3D%3D 9392700 (Pubitemid 27527771)
18. P. Karayiannis 2004 Current therapies for chronic hepatitis B virus infection Expert Rev Anti Infect Ther 2 745 760 10.1586/14789072.2.5.745 1:CAS:528:DC%2BD2cXpslGhtrs%3D 15482237
19. I. Ramazam 2005 Lamivudine prophylaxis in HBV carriers with haemato-oncological malignances who receive chemotherapy J Antimicrob Chemother 55 828 831 10.1093/jac/dki114 (Pubitemid 40883163)
20. F. Perez-Roldan P. Gonzalez-Carro M.C. Villafanez-Garcia 2005 Adefovir dipivoxil for chemotherapy-induced activation of hepatitis B virus infection N Engl J Med 352 310 311 10.1056/NEJM200501203520324 1:CAS:528: DC%2BD2MXmvVeksQ%3D%3D 15659742 (Pubitemid 40110831)
21. S. Locarnini A. Hatzakis J. Heathcote 2004 Management of antiviral resistance in patients with chronic hepatitis B Antivir Ther 9 679 693 1:CAS:528:DC%2BD2cXhtVKqsb%2FJ 15535405
22. Colson P, Borentain P, Coso D et al.: Entecavir as a first-line treatment for HBV reactivation following polychemotherapy for lymphoma. Br J Haematol 2008; 148-150.
23. D. Ming-Shen C. Tsu-Yi K. Woei-Yau 2004 Delayed hepatitis B virus reactivation after cessation of preemptive lamivudine in lymphoma patients treated with rituximab plus CHOP Ann Hematol 83 769 774 10.1007/s00277-004-0899- y (Pubitemid 39485548)
24. P.C. Lin S.B. Poh M.Y. Lee 2005 Fatal fulminant hepatitis B after withdrawal of prophylactic Lamivudine in hematopoietic stem cell transplantation patients Int J Hematol 81 340 351 10.1532/IJH97.A10411 (Pubitemid 41702099)
25. A.S. Lok B.J. McMahon 2007 Chronic hepatitis B Hepatology 45 507 539 10.1002/hep.21513 1:CAS:528:DC%2BD2sXisVKns7o%3D 17256718 (Pubitemid 46374607)
26. A.L. Mason L. Xu L. Guo 1998 Molecular basis for persistent hepatitis B infection in the liver after clearance of serum hepatitis B surface antigen Hepatology 27 1736 1742 10.1002/hep.510270638 1:CAS:528:DyaK1cXjvVCrs7w%3D 9620351 (Pubitemid 28264703)
27. H. Marusawa S. Uemoto M. Hijikata 2000 Latent hepatitis B virus infection in healthy individuals with antibodies to hepatitis B core antigen Hepatology 31 488 495 10.1002/hep.510310232 1:STN:280:DC%2BD3c7it1emsA%3D%3D 10655275
28. V. Mihm B.C. Gärtner D. Faust 2005 Viral kinetics in patients with lamivudine-resistant hepatitis B during adefovir-lamivudine combination therapy J Hepatol 43 217 224 10.1016/j.jhep.2005.02.037 1:CAS:528:DC%2BD2MXlvFals78%3D 15964093 (Pubitemid 40956873)
29. F. Marcucci A. Mele E. Spada 2006 High prevalence of hepatitis B virus infection in B-cell non Hodgkin's lymphoma Haematologica 9 554 557